Black-white disparities in HIV/AIDS: The role of drug policy and the corrections system

Journal of Health Care for the Poor and Underserved

Volumn 16, Issue 4 SUPPL. B, 2005, Pages 140-156

  Blankenship, Kim M ^a   Smoyer, Amy B ^a   Bray, Sarah J ^b   Mattocks, Kristin ^b  

^a YALE UNIVERSITY   (United States)

^b Eastern District of New York ^*

Author keywords

Corrections; Criminal justice; Drug policy; Drug use; HIV AIDS; Incarceration; Parole; Probation; Race disparities; Structural interventions

Indexed keywords

EID: 29144477574     PISSN: 10492089     EISSN: None     Source Type: Journal    
DOI: 10.1353/hpu.2005.0110     Document Type: Conference Paper

References (111)

1. Centers for Disease Control and Prevention (CDC). Fact Sheet - HIV/AIDS among African Americans. Atlanta: CDC, National Center for HIV, STD and TB Prevention, Division of HIV/AIDS Prevention (DHAP), 2004.
2. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2001 (Vol. 13). Atlanta: CDC, National Center for HIV, STD and TB Prevention, DHAP, 2002.
3. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2003 (Vol. 15). Atlanta: CDC, National Center for HIV, STD and TB Prevention, DHAP, 2004.
4. Kral AH, Bluthenthal RN, Booth RE, et al. HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. Am J Public Health. Jan 1998;88(1):108-13.
5. Day D. Health Emergency 1997: The spread of drug-related AIDS among African Americans and Latinos. Princeton, NJ: Dogwood Center, 1996.
6. Golub A, Johnson BD. Variation in youthful risks of progression from alcohol and tobacco to marijuana and to hard drugs across generations. Am J Public Health. Feb 2001;91(2):225-32.
7. Fuller CM, Vlahov D, Ompad DC, et al. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case control study. Drug Alcohol Depend 2002;66(2):189-98.
8. Fuller CM, Arria AM, Vlahov D, et al. Factors associated with adolescent imitation of injection drug use. Public Health Rep 2001;116(Suppl 1):136-45.
9. Kral AH, Lorvick J, Edlin BR. Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. J Acquir Immune Defic Syndr 2000;24(2):162-7.
10. Ellickson PL, Morton SC. Identifying adolescents at risk for hard drug use: racial/ethnic variations. J Adolesc Health 1999;25(6):382-95.
11. Substance Abuse and Mental Health Services Administration (SAMHSA).Results from the 2002 National Survey on Drug Use and Health. (Publication No. SMA 03-3836). Rockville, MD: SAMHSA, Office of Applied Studies, 2003.
12. Neaigus A, Miller M, Friedman S, et al. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction 2001;96(6):847-60.
13. McClelland GM, Teplin LA, Abram KM, et al. HIV and AIDS risk behaviors among female jail detainees: implications for public health policy. Am J Public Health 2002;92(5):818-25.
14. Smith DK, Gwinn M, Selik RM, et al. HIV/AIDS among African-Americans: Progress or progression? AIDS 2000;14(9):1237-48.
15. Belzer M, Rogers AS, Camarca M, et al. Contraceptive choices in HIV infected and HIV at-risk adolescent females. J Adolesc Health 2001;29(3 Suppl):93-100.
16. Anderson JE. Condom use and HIV risk among U.S. adults. Am J Public Health 2003;93(6):912-14.
17. Holtzman D, Bland SD, Lansky A, et al. HIV-related behaviors and perceptions among adults in 25 states: 1997 Behavioral Risk Factor Surveillance System. Am J Public Health. 2001;91(11):1882-8.
18. Soet JE, Dudley WN, Dilorio, C. The effects of ethnicity and perceived power on women's sexual behavior. Psychol of Women Q 1999;23(4):707-24.
19. Fife D, Mode C. AIDS incidence and income. J Acquir Immune Defic Syndr 1992;5(11):1105-10.
20. Hu DJ, Frey R, Costa SJ. Geographical AIDS rates and sociodemographic variables in Newark, New Jersey, metropolitan area. AIDS Public Policy J 1994;9:20-25.
21. Simon PA, Hu DJ, Diaz T, et al. Income and AIDS rates in Los Angeles county. AIDS 1995;9(3):281-4.
22. Wortley PM, Fleming PL. AIDS in women in the United States. Recent trends. JAMA 1997;278(11):911-6.
23. Weinreb L, Goldberg R, Lessard D, et al. HIV-risk practices among homeless and low-income housed mothers. J Fam Pract 1999;48(11):859-67.
24. Wallace R. Social disintegration and the spread of AIDS - II. Meltdown of sociogeographic structure in urban minority neighborhoods. Soc Sci Med 1993;37(7):887-96.
25. Lane SD, Rubinstein RA, Keefe RH, et al. Structural violence and racial disparity in HIV transmission. J Health Care Poor Underserved 2004;15(3):319-35.
26. Friedman SR, Sotheran JL, Abdul-Quader A, et al. The AIDS epidemic among Blacks and Hispanics. Milbank Q 1987;65(Suppl 2):455-99.
27. Friedman SR, Stepherson B, Woods J, et al. Society drug injectors and AIDS. J Health Care Poor Underserved 1992;3(1):73-89.
28. Mays VM, Cochran SD. Acquired immunodeficiency syndrome and black Americans: special psychosocial issues. Public Health Rep 1987;102(2):224-31.
29. Thomas SB, Quinn SC. The Tuskegee Syphilis Study, 1932 to 1972: implications for HIV education and AIDS risk education programs in the Black community. Am J Public Health 1991;81(11):1498-505.
30. Harrison PM, Karberg JC. Prison and jail inmates at midyear 2003. (National Criminal Justice (NCJ) Pub. 203947). Washington, DC: Bureau of Justice Statistics (BJS),2004.
31. Maguire K, Pastore AL, editors. Sourcebook of Criminal Justice Statistics 2002. (Pub. NCJ 203301). Washington, DC: BJS, 2004. http://www.albany.edu/ sourcebook/.
32. Harrison PM, Beck AJ. Prisoners in 2003. (Pub. NCJ 205335). Washington, DC: BJS, 2004.
33. Maguire K, Pastore AL, editors. Sourcebook of Criminal Justice Statistics 2003. Washington, DC: BJS, to appear. http://www.albany.edu/sourcebook/.
34. Bonczar TP, Beck AJ. Lifetime likelihood of going to state or federal prison. (Pub. NCJ 160092). Washington, DC: BJS, 1997.
35. Smoyer A, Blankenship KM. Drug policy: definition, discussion and state variation. New Haven, CT: Center for Interdisciplinary Research on AIDS, 2004.
36. Weich RH, Angulo CT. Justice on trial: racial disparities in the American criminal justice system. Washington DC: Leadership Conference on Civil Rights, 2000.
37. Mauer M. Race to Incarcerate. New York: The New Press, 1999.
38. Mumola CJ, Beck AJ. Prisoners in 1996. (Pub. NCJ 164619). Washington, DC: BJS, 1997.
39. Henderson DJ. Drug abuse and incarcerated women. A research review. J Subst Abuse Treat 1998;15(6):579-87.
40. Adams R, Onek D, Riker A. Double jeopardy: an assessment of the felony drug provision of the welfare reform act. San Francisco, CA: The Justice Policy Institute, 1998.
41. Maruschak LM. HIV in prisons and jails, 2002. (Pub. NCJ 205333). Washington, DC: BJS, 2004.
42. Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releases from US correctional facilities, 1997. Am J Public Health 2002;92(11):1789-94.
43. Bell C, Coven M, Cronan J, et al. Rape and sexual misconduct in the prison system: analyzing America's most "open" secret. Yale Law and Policy Review 1999;195(18):195-220.
44. Saum CA, Surratt HL, Inciardi JA, et al. Sex in prison: exploring the myths and realities. Prison Journal 1995;75(4):413-430.
45. Tewksbury R. Measures of sexual behavior in an Ohio prison. Sociol Soc Res 1989;74(1):34-9.
46. Wooden W, Parker J. Men behind bars: sexual exploitation in prison. New York: Plenum Press; 1982.
47. Belenko S, Langley S, Crimmins S, et al. HIV risk behaviors, knowledge, and prevention education among offenders under community supervision: a hidden risk group. AIDS Educ Prev 2004;16(4):367-85.
48. Kennedy DH, Nair G, Elliot L, et al. Drug misuse and sharing of needles in Scottish prisons. BMJ 1991;302(6791):1507.
49. Bird TG, Gore SM, Cameron S, et al. Anonymous HIV surveillance with risk factor elicitation at Scotland's largest prison, Barlinnie. AIDS 1995;9(7):801-8..
50. Dufour A, Alary M, Poulin C, et al. Prevalence and risk behaviors for HIV infection among inmates of a provincial prison in Quebec City. AIDS 1996;10(9):1009-15.
51. Taylor A, Goldberg D, Emslie J, et al. Outbreak of HIV infection in a Scottish prison. BMJ 1995;310(6975):289-92.
52. Correctional Service Canada. 1995 National Inmate Survey: Final Report. (Report No. SR-02). Ottawa: The Service (Correctional Research and Development), 1996.
53. Brewer TF, Vlahov D, Taylor E, et al. Transmission of HIV-1 within a statewide prison system. AIDS 1988;2(5):363-7.
54. Horsburgh CR Jr, Jarvis JQ, McArthur T, et al. Seroconversion to human immunodeficiency virus in prison inmates. Am J Public Health 1990;80(2):209-10.
55. Mutter RC, Grimes RM, Labarthe D. Evidence of intraprison spread of HIV infection. Arch Intern Med 1994;154(7):793-5.
56. Krebs CP, Simmons M. Intraprison HIV transmission: an assessment of whether it occurs, how it occurs, and who is at risk. AIDS Educ Prev 2002;14(5):53-64.
57. Wohl AR, Johnson D, Jordan W, et al. High-risk behaviors during incarceration in African-American men treated for HIV at three Los Angeles public medical centers. J Acquir Immune Defic Syndr 2000;24(4):386-92.
58. Inciardi JA, Lockwood D, Quinlan JA. Drug use in prison: patterns, processes, and implications for treatment. J Drug Issues 1993;23(1):119-29.
59. Kassira E, Bauserman R, Tomoyasu N, Caldeira E, Swetz A, Solomon L. HIV and AIDS surveillance among inmates in Maryland prisons. J Urban Health 2001;78(2):256-63.
60. Hoffman JP, Su SS, Pach A. Changes in network characteristics and HIV risk behaviors among injection drug users. Drug Alcohol Depend 1997;46(1/2):41-51.
61. Lane SD, Keefe RH, Rubinstein RA, et al. Marriage promotion and missing men: African-American women in a demographic double bind. Med Anthropol Q 2004;18(4):405-28.
62. Neaigus A, Friedman SR, Goldstein M, et al. Using dyadic data for a network analysis of HIV infection and risk behaviors among injection drug users. In: Needle RH, Coyle SL, Genser SG, et al, eds. Social Networks, Drug Abuse and HIV Transmission. NIDA Research Monograph 151. Rockville, MD: NIDA, 1995.
63. Hagan J, Dinovitzer R. Collateral consequences of imprisonment for children, communities, and prisoners. In: Tonry M, Petersilia J, eds. Prisons, Vol. 26. Chicago: University of Chicago Press, 1999.
64. Smith M, Clear TR. Fathers in prison: Interim Report. Draft report to the Edna McConnel Clark Foundation by the Rutgers University School of Criminal Justice, Newark, NJ, 1997.
65. Moore J. Bearing the burden: how incarceration policies weaken inner-city communities. In: Clear TR, ed. The unintended consequences of incarceration: papers from a conference organized by the Vera Institute of Justice. New York: Vera Institute of Justice, Inc., 1996.
66. Watts H, Nightingale DS. Adding it up: the economic impact of incarceration on individuals, families, and communities. In: The unintended consequences of incarceration: papers from a conference organized by the Vera Institute of Justice. New York: Vera Institute of Justice, Inc., 1996.
67. Buck M. Getting back to work: employment programs for ex-offenders. New York: Public/Private Ventures; 2000.
68. Iguchi MY, London JA, Forge NG, et al. Elements of well-being affected by criminalizing the drug user. Public Health Rep 2002;117(Suppl 1):S146-50.
69. Mumola CJ. Incarcerated parents and their children. (Pub. NCJ 182335). Washington DC: BJS, 2000.
70. Fagan J. Legal and illegal work: crime, work and unemployment. In: Weisbrod BA, Worthy JC, editors. The urban crisis: linking research to action. Evanston, IL: Northwestern University Press, 1997.
71. Travis J, Solomon AL, Waul M. From prison to home: the dimensions and consequences of prisoner reentry. Washington, D.C.: Urban Institute, 2001.
72. Petersilia J. When prisoners return to the community: political, economic, and social consequences. (Sentencing and Corrections: Issues for the 21st Century, No. 9). Washington DC: Department of Justice (DOJ), National Institute of Justice (NIJ), 2000.
73. Allard P. Life sentences: denying welfare benefits to women convicted of drug offenses. Washington, DC: The Sentencing Project, 2002.
74. Allard P. Life sentences: denying welfare benefits to women convicted of drug offenses (Summary). Washington DC: The Sentencing Project, 2004.
75. Nelson M, Trone J. Why planning for release matters. New York: Vera Institute of Justice, 2000.
76. Carey C. No second chance: people with criminal records denied access to public housing. New York, N.Y: Human Rights Watch, November 2004.
77. Hals K. From locked up to locked out: creating and implementing post-release housing for ex-prisoners. Seattle: AIDS Housing of Washington, 2003.
78. Gordon J. No rest for New York City's homeless with AIDS. Fortune News 2002;37(2):8-9.
79. Hankins C. Sexual transmission of HIV to women in industrialized countries. World Health Stat Q 1996;49(2):106-14.
80. Grella CE, Anglin MD, Wugalter SE, et al. Reasons for discharge from methadone maintenance for addicts at high risk of HIV infection or transmission. J Psychoactive Drugs 1994;26(2):223-32.
81. Bluthenthal RN, Lorvick J, Kral AH, et al. Collateral damage in the war on drugs: HIV risk behaviors among injection drug users. Int J Drug Policy 1999;10:25-38.
82. Stephens TT, Braithwaite R, Lubin J, et al. Homelessness and hunger as HIV risk factors for African American male commercial sex workers. J African American Men 2000;5(1):3-13.
83. Lundy C, Totten M. Youth on the fault line. Soc Work 1997;65(3):98-106.
84. Kral AH, Molnar BE, Booth RE, et al. Prevalence of sexual behaviour and substance use among runaway and homeless adolescents in San Francisco, Denver, and New York City. Int J STD AIDS 1997;8(2):109-17.
85. Beardsley M, Clatts MC, Deren S, et al. Homelessness and HIV risk behaviors in a sample of New York City drug injectors. AIDS and Public Policy Journal 1992;7(3):162-9.
86. Metzger DS, Navaline H, Woody GE. Drug abuse treatment as AIDS prevention. Public Health Rep 1998;113(Suppl 1):97-106.
87. Gibson DR, Flynn NM, McCarthy JJ. Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 1999;13(14):1807-1818.
88. Metzger DS, Woody GE, McLellan AT. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr 1993;6(9):1049-56.
89. Bellis DJ. Reduction of AIDS risk among 41 heroin addicted female street prostitutes: effects of free methadone maintenance. J Addict Dis 1993;12(1):7-23.
90. Ball JC, Lange WR, Myers CP, Friedman SR. Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav 1988;29(3):214-26.
91. Hartel DM, Schoenbaum EE. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Rep 1998;113(Suppl 1):107-115.
92. Glaze LE, Palla S. Probation and parole in the United States, 2003. (Pub. NCJ 205336). Washington, DC: BJS, 2003.
93. Austin J, Hardyman PL. The risks and needs of the returning prisoner population. Review of Policy Research 2004;21(1):13-20.
94. Epps AF. Unacceptable collateral damage: the danger of probation conditions restricting the right to have children. Creighton Law Review 2005;38(3):611-60.
95. Colbridge TD. Probationers, parolees, and the Fourth Amendment. FBI Law Enforcement Bulletin 2003;72(7):22-31.
96. Price-Livingston S. Search waivers for parolees and probationers. Office of Legislative Research (OLR) Research Report, No. 0022. Connecticut: Connecticut General Assembly, OLR, 2002.
97. Cohen J. Injecting reason: human rights and HIV prevention for injection drug users. California: a case study. Human Rights Watch 2003;15(2).
98. Grinstead O, Zack B, Faigleles B. Reducing post-release risk behavior among HIV seropositive prison inmates: the health promotion program. AIDS Educ Prevention 2001;13(2):109-19.
99. Brown BS, O'Grady KE, Battjes RJ, et al. Effectiveness of a stand-alone aftercare program for drug-involved offenders. J Subst Abuse Treat 2001;21(4):185-92.
100. Cornish JW, Metzger D, Woody GE, et al. Naltrexone pharmacotherapy for opioid dependent federal probationers. J Subst Abuse Treat 1997;14(6):529-34.
101. Prendergast ML, Wellisch J, Wong MM. Residential treatment for women parolees following prison-based treatment: treatment experiences, needs and services, outcomes. Prison Journal 1996;76(3):253-74.
102. Rose D, Clear TR. Incarceration, reentry, and social capital: social networks in the balance. In: Travis J, Waul M, eds. Prisoners once removed: the impact of incarceration and reentry on children, families, and communities. Washington, DC: Urban Institute, 2004; 313-41.
103. Austin J, Jacobson M. Building bridges: from conviction to employment. A proposal to reinvest corrections savings in an employment initiative. Connecticut: Council for State Governments, Criminal Justice Programs, 2003.
104. Hall EA, Baldwin DM, Prendergast ML. Women on parole: barriers to success after substance abuse treatment. Human Organization 2001;60(3):225-33.
105. Wood PB, May DC. Racial differences in perceptions of the severity of sanctions: a comparison of prison with alternatives. Justice Quarterly 2003;20(3):605-31.
106. Braithwaite RL, Arriola K. Male prisoners and HIV prevention: a call for action ignored. Am J Public Health 2003 May;93(5):759-63.
107. Hammett TM, Harmon P, Maruschak LM. 1996-1997 Update: HIV/AIDS, STDs and TB in correctional facilities. (Pub. NCJ-176344). Washington, D.C.: U.S. DOJ, NIJ, 1999.
108. Piper B, Briggs M, Huffman K, et al. State of the states: drug policy reforms: 1996-2002. NY: Drug Policy Alliance, September 2003.
109. Lines R, Jurgens R, Betteridge G, et al. Prison needle exchange: lessons from a comprehensive review of international evidence and experience. Montréal, Quebec: Canadian HIV/AIDS Legal Network, 2004.
110. Nelson M, Deess P, Allen C. The first month out: post-incarceration experiences in New York City. New York, NY: Vera Institute of Justice, 1999.
111. Petersilia J. When prisoners come home: parole and prisoner reentry. New York: Oxford University Press, 2003.